Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Lawrence A. Olatunji, Taofeek O. Usman, Young-Mi Seok & In-Kyeom Kim. (2017) Activation of cardiac renin–angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder. Archives of Physiology and Biochemistry 123:1, pages 1-8.
Read now
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Read now
Rossella E Nappi, Marco Serrani & Jeffrey T Jensen. (2014) Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. International Journal of Women's Health 6, pages 711-718.
Read now
Read now
Anne Burke. (2013) Nomegestrol acetate-17b-estradiol for oral contraception. Patient Preference and Adherence 7, pages 607-619.
Read now
Read now
Yvette Zimmerman, Herjan J. T. Coelingh Bennink, Wout Wouters, Frieda Ebes & Bart C. J. M. Fauser. (2013) The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive. The European Journal of Contraception & Reproductive Health Care 18:6, pages 489-500.
Read now
Read now
Yvette Zimmerman, Wout Wouters & Herjan J. T. Coelingh Bennink. (2013) The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone. The European Journal of Contraception & Reproductive Health Care 18:3, pages 206-214.
Read now
Read now
Diana Mansour, Carole Verhoeven, Werner Sommer, Edith Weisberg, Surasak Taneepanichskul, Gian Benedetto Melis, Inger Sundström-Poromaa & Tjeerd Korver. (2011) Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. The European Journal of Contraception & Reproductive Health Care 16:6, pages 430-443.
Read now
Read now
Ulla M. Ågren, Marjatta Anttila, Kristiina Mäenpää-Liukko, Maija-Liisa Rantala, Hilkka Rautiainen, Werner F. Sommer & Ellen Mommers. (2011) Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. The European Journal of Contraception & Reproductive Health Care 16:6, pages 444-457.
Read now
Read now
Articles from other publishers (39)
Shawna Gloe & Ty B. Carroll. (2023) Hormonal Contraceptive Use Is Associated With a Decreased Incidence of Hypothyroidism. Endocrine Practice.
Crossref
Crossref
Sarah Collet, Noor C Gieles, Chantal M Wiepjes, Annemieke C Heijboer, Tim Reyns, Tom Fiers, Bruno Lapauw, Martin den Heijer & Guy T'Sjoen. (2023) Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy. The Journal of Clinical Endocrinology & Metabolism 108:2, pages 331-338.
Crossref
Crossref
M H Kangasniemi, R K Arffman, S Joenväärä, A Haverinen, K Luiro, T Tohmola, R Renkonen, O Heikinheimo, J S Tapanainen & T T Piltonen. (2023) Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial. Human Reproduction 38:1, pages 89-102.
Crossref
Crossref
Bas P. H. Adriaansen, Mariska A. M. Schröder, Paul N. Span, Fred C. G. J. Sweep, Antonius E. van Herwaarden & Hedi L. Claahsen-van der Grinten. (2022) Challenges in treatment of patients with non-classic congenital adrenal hyperplasia. Frontiers in Endocrinology 13.
Crossref
Crossref
Marika H Kangasniemi, Riikka K Arffman, Annina Haverinen, Kaisu Luiro, Steinar Hustad, Oskari Heikinheimo, Juha S Tapanainen & Terhi T Piltonen. (2022) Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial. Contraception 116, pages 59-65.
Crossref
Crossref
Annina Haverinen, Kaisu Luiro, Marika H Kangasniemi, Terhi T Piltonen, Steinar Hustad, Oskari Heikinheimo & Juha S Tapanainen. (2022) Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis. The Journal of Clinical Endocrinology & Metabolism 107:7, pages e3008-e3017.
Crossref
Crossref
Saeideh Zareei, Fatemeh Behrasi, Mohammad Mehdi Naghizadeh, Fatemeh Talebzadeh, Ali Kharmandar, Sayed Hosein Davoodi, Maryam Asadi, Mojtaba Farjam & Reza Homayounfar. (2022) Oral contraceptive pill and metabolic syndrome: Fasa Persian Cohort Study (Descriptive study). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:2, pages 102408.
Crossref
Crossref
Samira Behboudi-Gandevani. 2022. Thyroid Diseases in Pregnancy. Thyroid Diseases in Pregnancy
241
250
.
Yuxuan Qiu, Yuanyuan Hu, Zhichao Xing, Qingyu Fu, Jingqiang Zhu & Anping Su. (2021) Birth control pills and risk of hypothyroidism: a cross-sectional study of the National Health and Nutrition Examination Survey, 2007–2012. BMJ Open 11:6, pages e046607.
Crossref
Crossref
Annina Haverinen, Marika Kangasniemi, Kaisu Luiro, Terhi Piltonen, Oskari Heikinheimo & Juha S. Tapanainen. (2021) Ethinyl estradiol vs estradiol valerate in combined oral contraceptives – Effect on glucose tolerance: A randomized, controlled clinical trial. Contraception 103:1, pages 53-59.
Crossref
Crossref
Alaa E. A. Moubasher, Hisham A. Abdel Basset, Asmaa A. M. Khalil & Eman M. K. Youssef. (2020) Levonorgestrel vs combined oral contraceptive pills in treatment of female acne and hirsutism. Dermatologic Therapy 33:6.
Crossref
Crossref
O.S. Michael, C.L. Dibia, O.A. Adeyanju, K.S. Olaniyi, E.D. Areola & L.A. Olatunji. (2020) Estrogen-progestin oral contraceptive and nicotine exposure synergistically confers cardio-renoprotection in female Wistar rats. Biomedicine & Pharmacotherapy 129, pages 110387.
Crossref
Crossref
Irene Scavello, Elisa Maseroli, Vincenza Di Stasi, Sarah Cipriani, Nunzia Verde, Angela Magini, Mario Maggi & Linda Vignozzi. (2019) Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study. International Journal of Impotence Research 32:2, pages 239-247.
Crossref
Crossref
Xin Sun, Fangbo Qian, Yaojuan He, Xiangying Gu & Wen Di. (2020) Safety and Efficacy of Combined Oral Contraceptive Ethinyl Estradiol/Drospirenone (YAZ) in Chinese Women: A Single-Arm, Open-Label, Multicenter, Post-Authorization Study. Advances in Therapy 37:2, pages 906-917.
Crossref
Crossref
Giuseppe Benagiano, Marisa Benagiano, Paola Bianchi, Mario Milco D'Elios & Ivo Brosens. (2019) Contraception in autoimmune diseases. Best Practice & Research Clinical Obstetrics & Gynaecology 60, pages 111-123.
Crossref
Crossref
Bao-Cheng Xie, Shu-Yong Song, Xiao-Yang Xie, Yu-Tong Sun, Xiao-Yuan Zhang, Dao-Hua Xu & Yun-Sheng Huang. (2019) Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate. Archiv der Pharmazie 352:3, pages 1800295.
Crossref
Crossref
Rik H.W. van Lunsen, Yvette Zimmerman, Herjan J.T. Coelingh Bennink, Hanneke M.M. Termeer, Nicole Appels, Bart C.J.M. Fauser & Ellen Laan. (2018) Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study. Contraception 98:1, pages 56-62.
Crossref
Crossref
Sneha G. Nair, Daxesh P. Patel, Mallika Sanyal, Puran Singhal & Pranav S. Shrivastav. (2018) Ultra-performance liquid chromatography-tandem mass spectrometry assay for determination of plasma nomegestrol acetate and estradiol in healthy postmenopausal women. Biomedical Chromatography 32:2, pages e4086.
Crossref
Crossref
Júnia Raquel Dutra Ferreira, Milena Magalhães Aleluia, Camylla Vilas Boas Figueiredo, Larissa Castro de Lima Vieira, Rayra Pereira Santiago, Caroline Conceição da Guarda, Cynara Gomes Barbosa, Ricardo Riccio Oliveira, Elisângela Vitória Adorno & Marilda de Souza Gonçalves. (2017) Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives. Frontiers in Endocrinology 8.
Crossref
Crossref
Salvatore CarusoStefano CianciMaria CariolaValentina FavaSalvatore Di PasquaAntonio Cianci. (2017)
Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17
β
-Estradiol
. Journal of Women's Health 26:7, pages 728-734.
Crossref
Crossref
Diana Mansour, Carolyn Westhoff, Uma Kher & Tjeerd Korver. (2017) Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17?-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women. Contraception 95:4, pages 390-397.
Crossref
Crossref
Renate Louw-du Toit, Karl-Heinz Storbeck, Meghan Cartwright, Angelique Cabral & Donita Africander. (2017) Progestins used in endocrine therapy and the implications for the biosynthesis and metabolism of endogenous steroid hormones. Molecular and Cellular Endocrinology 441, pages 31-45.
Crossref
Crossref
Renate Louw-du Toit, Meghan S. Perkins, Jacky L. Snoep, Karl-Heinz Storbeck & Donita Africander. (2016) Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids. PLOS ONE 11:10, pages e0164170.
Crossref
Crossref
Rulin Wang, Yuan Tian, Lin Zhang & Zunjian Zhang. (2016) Simultaneous determination of levonorgestrel and two endogenous sex hormones in human plasma based on LC–MS/MS. Bioanalysis 8:11, pages 1133-1144.
Crossref
Crossref
Y. Zimmerman, J.-M. Foidart, A. Pintiaux, J.-M. Minon, B.C.J.M. Fauser, K. Cobey & H.J.T. Coelingh Bennink. (2015) Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects. Contraception 91:2, pages 127-133.
Crossref
Crossref
Tue S?eborg, Hanne Frederiksen, Annette Mouritsen, Trine Holm Johannsen, Katharina Maria Main, Niels J?rgensen, J?rgen Holm Petersen, Anna-Maria Andersson & Anders Juul. (2014) Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17?-hydroxyprogesterone, ?4-androstenedione, testosterone and their ratios in children, adolescents and young adults. Clinica Chimica Acta 437, pages 6-13.
Crossref
Crossref
Laureen M Lopez, David A Grimes & Kenneth F Schulz. (2014) Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database of Systematic Reviews 2019:11.
Crossref
Crossref
M. Raps, J. Curvers, F.M. Helmerhorst, B.E.P.B. Ballieux, J. Rosing, S. Thomassen, F.R. Rosendaal & H.A.A.M. van Vliet. (2014) Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives. Thrombosis Research 133:4, pages 640-644.
Crossref
Crossref
He-Lin Lu, Zong-Wen Wu, Shu-Yong Song, Xiao-Dan Liao, Yan Zhu & Yun-Sheng Huang. (2014) An Improved Synthesis of Nomegestrol Acetate. Organic Process Research & Development 18:3, pages 431-436.
Crossref
Crossref
Y. Zimmerman, M. J. C. Eijkemans, H. J. T. Coelingh Bennink, M. A. Blankenstein & B. C. J. M. Fauser. (2013) The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update 20:1, pages 76-105.
Crossref
Crossref
George K. Creatsas & Maria Creatsas. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
25
27
.
Anna Maria Aloisi, Stella Vodo & Michelangelo Buonocore. (2013) Pain and thyroid hormones. Neurological Sciences 34:9, pages 1501-1508.
Crossref
Crossref
Lee P Shulman. (2013) Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen. Journal of Family Planning and Reproductive Health Care 39:3, pages 211-216.
Crossref
Crossref
Mireille G.F. Gerrits, Peter G. Schnabel, Teun M. Post & Pierre A.M. Peeters. (2013) Pharmacokinetic profile of nomegestrol acetate and 17?-estradiol after multiple and single dosing in healthy women. Contraception 87:2, pages 193-200.
Crossref
Crossref
Carolyn L. Westhoff, Kelsey A. Petrie & Serge Cremers. (2013) Using changes in binding globulins to assess oral contraceptive compliance. Contraception 87:2, pages 176-181.
Crossref
Crossref
Laureen M Lopez, Mario Chen, Deborah Hilgenberg, Julie Denison & Gretchen Stuart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lily P.H. Yang & Greg L. Plosker. (2012) Nomegestrol Acetate/Estradiol. Drugs 72:14, pages 1917-1928.
Crossref
Crossref
Carolyn Westhoff, Andrew M. Kaunitz, Tjeerd Korver, Werner Sommer, Luis Bahamondes, Philip Darney & Carole Verhoeven. (2012) Efficacy, Safety, and Tolerability of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate and 17β-Estradiol. Obstetrics & Gynecology 119:5, pages 989-999.
Crossref
Crossref
Xiangyan Ruan, Harald Seeger & Alfred O. Mueck. (2012) The pharmacology of nomegestrol acetate. Maturitas 71:4, pages 345-353.
Crossref
Crossref